Spots Global Cancer Trial Database for localized transitional cell cancer of the renal pelvis and ureter

Every month we try and update this database with for localized transitional cell cancer of the renal pelvis and ureter cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	NCT01846520	Healthy Subject Localized Trans... Metastatic Tran... Psychosocial Ef... Recurrent Bladd... Recurrent Cervi... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Renal... Recurrent Trans... Recurrent Ureth... Recurrent Uteri... Regional Transi... Stage II Bladde... Stage II Renal ... Stage II Urethr... Stage IIA Cervi... Stage IIA Colon... Stage IIA Gastr... Stage IIA Ovari... Stage IIA Ovari... Stage IIA Pancr... Stage IIA Recta... Stage IIA Uteri... Stage IIB Cervi... Stage IIB Colon... Stage IIB Gastr... Stage IIB Ovari... Stage IIB Ovari... Stage IIB Pancr... Stage IIB Recta... Stage IIB Uteri... Stage IIC Colon... Stage IIC Ovari... Stage IIC Ovari... Stage IIC Recta... Stage III Bladd... Stage III Pancr... Stage III Renal... Stage III Ureth... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Gast... Stage IIIA Ovar... Stage IIIA Ovar... Stage IIIA Rect... Stage IIIA Uter... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Gast... Stage IIIB Ovar... Stage IIIB Ovar... Stage IIIB Rect... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Ovar... Stage IIIC Ovar... Stage IIIC Rect... Stage IIIC Uter... Stage IV Bladde... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Renal ... Stage IV Urethr... Stage IVA Cervi... Stage IVA Colon... Stage IVA Recta... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Colon... Stage IVB Recta... Stage IVB Uteri... Ureter Cancer Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... Stage IIIB Lung...	educational int... telephone-based... quality-of-life... questionnaire a...	18 Years -	City of Hope Medical Center
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer	NCT00003342	Bladder Cancer Transitional Ce...	filgrastim carboplatin doxorubicin hyd... gemcitabine hyd... paclitaxel	18 Years -	Memorial Sloan Kettering Cancer Center
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium	NCT00082719	Bladder Cancer Urethral Cancer	Recombinant Int...	-	M.D. Anderson Cancer Center
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium	NCT00045630	Bladder Cancer Transitional Ce... Urethral Cancer	carboplatin gemcitabine paclitaxel surgery	18 Years -	SWOG Cancer Research Network
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer	NCT01118039	Bladder Cancer Transitional Ce... Urethral Cancer	sunitinib malat... immunohistochem... laboratory biom... pharmacological... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer	NCT01118039	Bladder Cancer Transitional Ce... Urethral Cancer	sunitinib malat... immunohistochem... laboratory biom... pharmacological... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants	NCT00900276	Bladder Cancer Kidney Cancer Transitional Ce... Urethral Cancer	immunologic tec... laboratory biom... mass spectromet...	18 Years - 120 Years	Wake Forest University Health Sciences
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer	NCT00028860	Bladder Cancer Transitional Ce...	filgrastim carboplatin gemcitabine hyd... ifosfamide paclitaxel adjuvant therap...	-	National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer	NCT01118039	Bladder Cancer Transitional Ce... Urethral Cancer	sunitinib malat... immunohistochem... laboratory biom... pharmacological... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium	NCT00363883	Localized Trans... Metastatic Tran... Recurrent Trans... Regional Transi... Transitional Ce...	vorinostat laboratory biom...	18 Years -	National Cancer Institute (NCI)
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium	NCT00045630	Bladder Cancer Transitional Ce... Urethral Cancer	carboplatin gemcitabine paclitaxel surgery	18 Years -	SWOG Cancer Research Network
Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer	NCT00003342	Bladder Cancer Transitional Ce...	filgrastim carboplatin doxorubicin hyd... gemcitabine hyd... paclitaxel	18 Years -	Memorial Sloan Kettering Cancer Center
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer	NCT01639521	Anterior Urethr... Localized Trans... Posterior Ureth... Recurrent Bladd... Recurrent Ureth... Regional Transi... Stage III Bladd... Transitional Ce... Ureter Cancer Urethral Cancer...	cisplatin gemcitabine hyd... methotrexate vinblastine doxorubicin hyd... pegfilgrastim laboratory biom...	18 Years -	University of Southern California

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: